HUNTSMAN CANCER INSTITUTE.

AuthorCole, Kelleigh
PositionBrief Article

Salt Lake City -- The HUNTSMAN CANCER INSTITUTE and SUPERGEN PHARMACEUTICALS announced an agreement to conduct a Phase I clinical trial for patients with solid tumors that have failed standard therapy. As part of the trial, patients will be given the anti-cancer...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT